Wuhan DR Laser Technology (300776) Fundamentals 2026 — P/E 61.0x, Revenue Analysis | SniperIQ
Wuhan DR Laser Technology (300776) is a CN-listed Industrials company in Industrial - Machinery with a market capitalization of ¥33.1B, trading at ¥116.42 on the SHZ. This SniperIQ fundamentals page covers Wuhan DR Laser Technology's valuation (P/E 61.0x, P/B 8.1x), profitability (net margin 27.4%), revenue (¥2.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Wuhan DR Laser Technology's market cap?
Wuhan DR Laser Technology (300776) has a market capitalization of approximately ¥33.1B, trading at ¥116.42 on the SHZ. Market cap moves with the live share price.
What is Wuhan DR Laser Technology's P/E ratio?
Wuhan DR Laser Technology's trailing twelve-month P/E ratio is 61.0x, with a price-to-book (P/B) of 8.1x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Wuhan DR Laser Technology?
Wuhan DR Laser Technology runs a net profit margin of 27.4%, a gross margin of 26.5%, and an operating margin of 30.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Wuhan DR Laser Technology generate?
Wuhan DR Laser Technology reported revenue of ¥2.0B for fiscal year 2025, with net income of ¥519M and earnings per share (EPS) of 1.91. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Wuhan DR Laser Technology pay a dividend?
Wuhan DR Laser Technology offers a trailing dividend yield of about 0.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Wuhan DR Laser Technology financially healthy?
Wuhan DR Laser Technology carries a debt-to-equity ratio of 0.28x and a current ratio of 3.55x, with a market beta of 0.78. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Wuhan DR Laser Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Wuhan DR Laser Technology (300776) the key facts are: market cap ¥33.1B, P/E 61.0x, revenue ¥2.0B, 52-week range 56.21-218. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Wuhan DR Laser Technology's full fundamentals live
Get Wuhan DR Laser Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.